Recent News

BUSINESS ONE-STOP LAUNCHED (6/1/08) The Commonwealth of Virginia has announced the launch of Business One Stop, an online tool designed to assist Virginia entrepreneurs in starting a business. The service provides prospective start-up companies with a customized list of the business formation steps, forms, and potential assistance resources.

U.VA. START-UPS RECOGNIZED FOR INNOVATION (5.22.08) At its Innovation Awards dinner, the Charlottesville Business Innovation Council (CBIC) recently recognized several U.Va. start-ups for their noteworthy contributions to the marketplace. Finalists for the Rocket Award included Avir Sensors and PocketMed, while Cellular Materials International received the Breakthrough Award.

U.VA. PATENT FOUNDATION LICENSES SILVER NANOPARTICLE TECHNOLOGY TO U.VA. START-UP PLUROGEN THERAPEUTICS INC. (04.21.08) The new technology will be used as an enhanced anti-microbial agent to fight infection and promote wound-healing.

U.VA. RESEARCHERS SPERM-CHECK HOME TEST RECEIVES FDA OK (03.05.08) Earlier this year, the U.S. Food and Drug Administration approved SpermCheck Vasectomy, a home test that confirms men's post-vasectomy sterility and is based on discoveries made at U.Va.

LANDERS RECIVES ALA INNOVATION AWARD AT LABAUTOMATION2008 (02.07.08) James Landers of T100's Microlab Diagnostics was recently recognized with the 2008 Innovation Award from the Association for Laboratory Automation (ALA) for his novel Microfluidic Genetic Analysis (MGA) technology.

T100'S CATO LAURENCIN RECOGNIZED FOR ACL BREAKTHROUGHS (01.02.08) U.Va. Professor, Cato Laurencin, has been named to the 2007 Scientific American 50 for his groundbreaking technology for regeneration of the anterior cruciate ligament (ACL) using a bioengineered matrix. This technology is a component of Healing Orthopaedic Technologies, a T100 company.

PLUROGEN THERAPEUTICS PARTNERS WITH WELCARE INDUSTRIES (12.27.07) T100 graduate, PluroGen, has partnered with European wound and skin cleansing leader, Welcare, to develop and commercialize its topical gel products.

NEW HAND-HELD SOFTWARE RELEASED (11.29.07) T100 company, PocketMed, has released its latest version of PocketBilling, a hand-held device that streamlines medical billing.

BUSINESS ADVANTAGE CIRCLES (11.15.07) The Small Business Development Center's new peer advisory program is accepting membership applications. This new program provides a confidential, non-competitive forum for problem solving, sharing best practices, and, ultimately, contributing to the success of members’ businesses.

MEDICAL DEVICE COMMERCIALIZATION: LESSONS FROM THE FRONT LINES (11.08.07) Scott Phillips, president and founder of Starfish Medical, presented a series of case studies on medical products developed over the past decade with various outcomes. He highlighted pitfalls and success strategies as well as a successful development methodology.

LIVE FIRE FORUM APPLICATIONS NOW BEING ACCEPTED (10.27.07) The Charlottesville Business Innovation Council (CBIC) is accepting applications for its Live Fire Forum on Dec. 7. Companies seeking pre-institutional funding may be selected to present to representatives from four angel networks. Application deadline is Nov. 16.

DIAKINE THERAPEUTICS' ANTI-DIABETES DRUG FEATURED IN REPORT TO CONGRESS (10.25.07) DiaKine's research, showing that its developmental drug, Lisofylline (LSF), prevented the recurrence of type 1 diabetes after islet cell transplantation in mice, is part of the status report on efforts to eradicate diabetes by the NIH. DiaKine is one of U.Va.'s T100 companies.

LOCAL TECHNOLOGY AND ENTREPRENEURIAL GROUPS REORGANIZE (10.02.07) The Virginia Piedmont Technology Council + Charlottesville Venture Group (VPTC+CVG) has reorganized and recently announced its new name. The Charlottesville Business Innovation Council (CBIC) will combine the VPTC’s technology focus and the CVG’s commitment to entrepreneurial education.

2007 MID-ATLANTIC BIO CONFERENCE (08.21.07) is accepting applications from life sciences companies to present their pitch for funding. Poster abstracts may also be submitted for acceptance into the Innovation Corridor. Deadline for all applications is Sept. 7.

ADENOSINE THERAPEUTICS (ATL) ANNOUNCES FUNDING DEAL (06.18.07) ATL has announced that the Novartis Option Fund is leading the Company’s $14 million series “C” financings. In a separate agreement, Novartis acquired an option to develop ATL's novel oral drugs for diabetes and asthma.

T100 COMPANY HONORED WITH VPTC+CVG BREAKTHROUGH AWARD (06.06.07) At its recent Tech Awards dinner, the VPTC+CVG awarded its Breakthrough Award to DiaKine Therapeutics. This U.Va. start-up, founded by Jerry Nadler, Mary Ann Nadler and Keith Ignotz, is developing innovative diabetes therapies. The Breakthrough Award recognizes a technology-based company that has made a quantum advance in its field of expertise.

SE BIO INVESTOR FORUM LOOKING FOR A FEW GOOD COMPANIES (05.01.07) Emerging life sciences companies are invited to apply to the 2007 Investor Forum, including the opportunity to present their investment needs to a broad range of investors from throughout the SE region. Since 1999, Investor Forum companies have raised over $2B. Application deadline has been extended to July 18.

NEW EMERGING LIFE SCIENCE GAP FUND ANNOUNCED (03.15.07) The Center for Innovative Technology has announced the launch of the new GAP BioLife Fund. This seed stage venture fund will specifically focus on new life science company formation resulting from technology transfer collaboration with Virginia's universities and federal labs.

VPTC AND CVG UNITE (02.22.07) Two local organizations have joined forces to focus on entrepreneurship and technology-based economic development. The Virginia Piedmont Technology Council (VPTC), recognized as a leader in the technology sector, and the Charlottesville Venture Group (CVG), known for its leadership in the entrepreneurial business sector, will offer a broad range of programs, ultimately leading to a more diversified and balanced regional economy.